Ohio Innovation Fund

Ohio Innovation Fund is a venture capital firm based in Columbus, Ohio, specializing in early-stage and startup investments. Founded in 2016, the firm focuses on the technology sector, with particular interest in medical technology, biopharma, augmented and virtual reality, advanced manufacturing, software as a service, artificial intelligence, machine learning, cybersecurity, and mobility. Ohio Innovation Fund primarily invests in companies located in Ohio, typically providing funding between $250,000 and $500,000, with the potential for up to $1.25 million based on specific milestones achieved by the companies.

William Baumel

Managing Director

JIll Raderstorf

Partner

Faith Voinovich

Principal

33 past transactions

Enable Injections

Series C in 2022
Enable Injections designs, manufactures, and sells wearable delivery devices for injectable drugs. The Enable Injections products can deliver drugs directly from standard vials supplied by all pharmaceutical companies, can reconstitute powdered drugs into liquids as a part of the injection procedure, can inject very viscous drugs, and can inject up to 20 ml. Such products are called bolus injection systems. No other existing drug delivery device can accomplish all of these tasks. For inquiries, telephone and contact numbers are used. Approximately 900 new drugs are being developed that may require bolus injection technology like that being developed by Enable Injections. The total market is expected to reach $8 billion within ten years. Partisan principals have supplied 10% of the seed capital to Enable Injections. It also delivers a controlled flow of up to 50 ml of a biologic through an automatically inserted needle. Enable Injections also offers a version of the drug delivery platform that may connect to smartphones via Bluetooth. It also utilizes any standard container closure system, including syringes or vials; automatically warms and can automatically mix lyophilized solutions. Enable Injections was founded in 2010 and is headquartered in Cincinnati, Ohio, USA.

Aware

Series C in 2021
Aware is a cloud intelligence platform that adopts the latest advancements in cognitive computing, artificial intelligence, and behavioral analytics to amplify enterprise value by monitoring the social graph. They harness the power of their platform’s insights into human behavior and interactivity to create great value for the enterprise.

DAtAnchor

Convertible Note in 2021
Traditional IT controls focus on locking down networks, devices, and people. All of this is done in the name of protecting data. But, once files are moved, shared, or stolen, the data is no longer protected. Even worse, these controls get in the way and frustrate business users to the point they intentionally work around them. Anchor inverts the equation by baking protection into the data, invisible to the business users (like antivirus), so that files are free to travel and security is out of the way. Simply put, wherever the data goes, it is protected. Anchor is a SaaS platform, with an endpoint component, that bakes protection into your files with a unique transparent combination of encryption, continuous multi-factor access controls, and a digital chain of custody. And when you do share or collaborate, Anchor protection stays with your data, even when it leaves your organization. Anchor empowers you to maintain control of your files while collaborating on premise or in the cloud, including forensic logging and revoking access. In under 90 minutes, Anchor is fully deployed and empowers your business users to securely work and collaborate without complicated security products or rules in the way. All without requiring you to change existing IT controls or how your users and applications work today. DAtAnchor is a result of a multi-year research activity, developed at Ohio State University. The development team currently has 6 members, 4 of which are full-time. We have seed level funding for >1M and an advisory board with members at the senior vice president level in Fortune 500 companies.

S4 Medical

Series A in 2021
Sotera is a medical device company that focuses on innovative solutions for cardiac procedures. The company’s initial product is a solution for reducing complications to the esophagus during catheter ablation treatment for atrial fibrillation. It is commercializing a novel medical device designed to protect the esophagus during catheter ablation procedures.

eFuse

Venture Round in 2021
eFuse is a web and mobile application for the Esports & video game industry. eFuse allows individuals to establish their gaming identity and participate in the industry at all levels. Whether it be learning about the industry, networking with other like-minded individuals, or accessing opportunities like jobs & scholarships, eFuse has something for everyone. eFuse is based in Columbus, Ohio and was founded in 2018.

Aware

Series B in 2020
Aware is a cloud intelligence platform that adopts the latest advancements in cognitive computing, artificial intelligence, and behavioral analytics to amplify enterprise value by monitoring the social graph. They harness the power of their platform’s insights into human behavior and interactivity to create great value for the enterprise.

ScriptDrop

Series A in 2020
ScriptDrop’s technology platform enables connectivity across the healthcare ecosystem connecting patients, pharmacists, providers, and pharmaceutical manufacturers. The platform provides a seamless experience for patients, offering them prescription delivery in all 50 states and allowing for important additional services to be provided for better adherence. The company was founded in 2016 and is headquartered in Columbus, Ohio.

Immuta

Series C in 2020
Immuta enables organizations to unlock value from their cloud data by protecting it and providing secure access. The Immuta Data Security Platform provides sensitive data discovery, security and access control, data activity monitoring, and has deep integrations with the leading cloud data platforms. Immuta is now trusted by Fortune 500 companies and government agencies around the world to secure their data. Founded in 2015, Immuta is headquartered in Boston, MA.

Genetesis

Series B in 2020
Genetesis is a rapidly growing medical technology company redefining the way patients with a risk of myocardial ischemia and coronary artery disease are clinically diagnosed, monitored and screened.

S4 Medical

Venture Round in 2020
Sotera is a medical device company that focuses on innovative solutions for cardiac procedures. The company’s initial product is a solution for reducing complications to the esophagus during catheter ablation treatment for atrial fibrillation. It is commercializing a novel medical device designed to protect the esophagus during catheter ablation procedures.
EmployStream is a hiring workflow automation software platform for staffing companies and other high-volume employers. It also creates high-quality, user-friendly for high-volume employers that automates the hiring and onboarding process for employers. The platform eliminates costly mistakes and delays allowing companies to hire up to 90% faster and at half the cost. The company provides an online hiring platform which offers different features such as paper onboarding, real-time alerting, online application, background checks, applicant pre & interview screening, and verification. EmployStream was founded in 2014 and is headquartered in Cleveland Ohio, USA.

Windpact

Venture Round in 2019
Windpact is a provider of impact protection solutions designed for sports, military, and automotive applications. The company's protection solutions are empowered with refined machine learning principles, FEA modeling, and a Crash Cloud system that automatically adjusts to manage a wide range of impact rates, protecting people anywhere exposed to the risk of impact. Windpact was founded in 2011 and is headquartered in Leesburg, Virginia.

eFuse

Seed Round in 2019
eFuse is a web and mobile application for the Esports & video game industry. eFuse allows individuals to establish their gaming identity and participate in the industry at all levels. Whether it be learning about the industry, networking with other like-minded individuals, or accessing opportunities like jobs & scholarships, eFuse has something for everyone. eFuse is based in Columbus, Ohio and was founded in 2018.
EmployStream is a hiring workflow automation software platform for staffing companies and other high-volume employers. It also creates high-quality, user-friendly for high-volume employers that automates the hiring and onboarding process for employers. The platform eliminates costly mistakes and delays allowing companies to hire up to 90% faster and at half the cost. The company provides an online hiring platform which offers different features such as paper onboarding, real-time alerting, online application, background checks, applicant pre & interview screening, and verification. EmployStream was founded in 2014 and is headquartered in Cleveland Ohio, USA.

Complion

Series B in 2019
Complion platform offers tremendous benefits to every role in the clinical trial ecosystem. It allows administrators and research coordinators to more efficiently maintain compliance protocols. It unleashes investigators to explore potential innovation with fewer hassles. It streamlines crucial information that auditors and quality assurance personnel need and it permits collaborators and reviewers to more easily participate in clinical research.

Stirling Ultracold

Series B in 2018
Stirling Ultracold, a division of Global Cooling, Inc., is a developer and manufacturer of a new generation of environmentally friendly ultra-low temperature freezers which operate below -86°C. These freezers do not use dry ice, Peltier or conventional cascade refrigeration systems. Instead, the Stirling Ultracold product line operates on free-piston Stirling engine technology.

DAtAnchor

Seed Round in 2018
Traditional IT controls focus on locking down networks, devices, and people. All of this is done in the name of protecting data. But, once files are moved, shared, or stolen, the data is no longer protected. Even worse, these controls get in the way and frustrate business users to the point they intentionally work around them. Anchor inverts the equation by baking protection into the data, invisible to the business users (like antivirus), so that files are free to travel and security is out of the way. Simply put, wherever the data goes, it is protected. Anchor is a SaaS platform, with an endpoint component, that bakes protection into your files with a unique transparent combination of encryption, continuous multi-factor access controls, and a digital chain of custody. And when you do share or collaborate, Anchor protection stays with your data, even when it leaves your organization. Anchor empowers you to maintain control of your files while collaborating on premise or in the cloud, including forensic logging and revoking access. In under 90 minutes, Anchor is fully deployed and empowers your business users to securely work and collaborate without complicated security products or rules in the way. All without requiring you to change existing IT controls or how your users and applications work today. DAtAnchor is a result of a multi-year research activity, developed at Ohio State University. The development team currently has 6 members, 4 of which are full-time. We have seed level funding for >1M and an advisory board with members at the senior vice president level in Fortune 500 companies.

Enable Injections

Series B in 2018
Enable Injections designs, manufactures, and sells wearable delivery devices for injectable drugs. The Enable Injections products can deliver drugs directly from standard vials supplied by all pharmaceutical companies, can reconstitute powdered drugs into liquids as a part of the injection procedure, can inject very viscous drugs, and can inject up to 20 ml. Such products are called bolus injection systems. No other existing drug delivery device can accomplish all of these tasks. For inquiries, telephone and contact numbers are used. Approximately 900 new drugs are being developed that may require bolus injection technology like that being developed by Enable Injections. The total market is expected to reach $8 billion within ten years. Partisan principals have supplied 10% of the seed capital to Enable Injections. It also delivers a controlled flow of up to 50 ml of a biologic through an automatically inserted needle. Enable Injections also offers a version of the drug delivery platform that may connect to smartphones via Bluetooth. It also utilizes any standard container closure system, including syringes or vials; automatically warms and can automatically mix lyophilized solutions. Enable Injections was founded in 2010 and is headquartered in Cincinnati, Ohio, USA.

Alviere

Series A in 2018
Alviere is a finance platform that provides embedded financial products and technology to its customers. It streamlines and automates the delivery of financial products like banking, mobile payments, card issuance, payment processing, and cross-border currency exchange, enabling its clients to strengthen customer relationships, increase revenue and maximize profits.

RXQ Compounding

Series A in 2018
RXQ Compounding, LLC is an FDA Approved 503B Outsourcing Facility, currently located within the Ohio University Innovation Center in Athens, Ohio. They have partnered with the Ohio University Innovation Center to develop a viable enterprise here in Southern Ohio. RXQ Compounding, LLC is poised to be a leader in the new paradigm of manufacturing facilities across the country. Their team designed and implemented a stringent procedural manual that is now copyrighted. Other 503B Outsourcing Facilities that follow into this new realm will be hard pressed to find a more complete adaptation of the new regulations. RXQ Compounding, LLC emerged in front of new regulations from the FDA governing compounding facilities and the state board of pharmacy to assure that the safest products are delivered to our customers and patients.

Eccrine Systems

Series B in 2018
Eccrine Systems is developing non-invasive, electronic wearable systems that measure and transmit real-time data about human sweat. The ability to monitor sweat biomarkers with chronological accuracy is the key to attaining market-enabling improvements in the predictive value of non-invasive wearables data - across a wide spectrum of applications for medicine, industry, and sport. Eccrine Systems collaborates with capable downstream partners who have deep understanding of vertical application opportunities, enabling the translation of our foundational technology and IP portfolio into market leading products and solutions.

Mezu

Venture Round in 2018
Mezu is a mobile payment app that gives you a private and secure way to give and get money without sharing your personal information. Just like cash, with Mezu, you can conveniently pay, tip, earn and donate safely and for free. Because Mezu believes that what you do with your money is your business. Mezu is now available on iOS and Android in the United States. Sign up and learn more: https://www.mezu.com.

Genetesis

Series A in 2018
Genetesis is a rapidly growing medical technology company redefining the way patients with a risk of myocardial ischemia and coronary artery disease are clinically diagnosed, monitored and screened.

Immuta

Series B in 2018
Immuta enables organizations to unlock value from their cloud data by protecting it and providing secure access. The Immuta Data Security Platform provides sensitive data discovery, security and access control, data activity monitoring, and has deep integrations with the leading cloud data platforms. Immuta is now trusted by Fortune 500 companies and government agencies around the world to secure their data. Founded in 2015, Immuta is headquartered in Boston, MA.

ConnXus

Series A in 2018
ConnXus supplier management solutions simplify the complexities of global supply chains and allow buyers to achieve their goals of responsible and sustainable sourcing. ConnXus is a NMSDC, CPUC, CAMSC and State of Ohio-certified minority-owned business enterprise based in Mason, Ohio with local, regional and international capabilities.

Aware

Series A in 2018
Aware is a cloud intelligence platform that adopts the latest advancements in cognitive computing, artificial intelligence, and behavioral analytics to amplify enterprise value by monitoring the social graph. They harness the power of their platform’s insights into human behavior and interactivity to create great value for the enterprise.

Immuta

Series A in 2017
Immuta enables organizations to unlock value from their cloud data by protecting it and providing secure access. The Immuta Data Security Platform provides sensitive data discovery, security and access control, data activity monitoring, and has deep integrations with the leading cloud data platforms. Immuta is now trusted by Fortune 500 companies and government agencies around the world to secure their data. Founded in 2015, Immuta is headquartered in Boston, MA.

Aware

Series A in 2017
Aware is a cloud intelligence platform that adopts the latest advancements in cognitive computing, artificial intelligence, and behavioral analytics to amplify enterprise value by monitoring the social graph. They harness the power of their platform’s insights into human behavior and interactivity to create great value for the enterprise.

Aware

Series A in 2017
Aware is a cloud intelligence platform that adopts the latest advancements in cognitive computing, artificial intelligence, and behavioral analytics to amplify enterprise value by monitoring the social graph. They harness the power of their platform’s insights into human behavior and interactivity to create great value for the enterprise.

Enable Injections

Series A in 2016
Enable Injections designs, manufactures, and sells wearable delivery devices for injectable drugs. The Enable Injections products can deliver drugs directly from standard vials supplied by all pharmaceutical companies, can reconstitute powdered drugs into liquids as a part of the injection procedure, can inject very viscous drugs, and can inject up to 20 ml. Such products are called bolus injection systems. No other existing drug delivery device can accomplish all of these tasks. For inquiries, telephone and contact numbers are used. Approximately 900 new drugs are being developed that may require bolus injection technology like that being developed by Enable Injections. The total market is expected to reach $8 billion within ten years. Partisan principals have supplied 10% of the seed capital to Enable Injections. It also delivers a controlled flow of up to 50 ml of a biologic through an automatically inserted needle. Enable Injections also offers a version of the drug delivery platform that may connect to smartphones via Bluetooth. It also utilizes any standard container closure system, including syringes or vials; automatically warms and can automatically mix lyophilized solutions. Enable Injections was founded in 2010 and is headquartered in Cincinnati, Ohio, USA.

Spirosure

Series C in 2016
Spirosure develops breath-analysis devices to apply novel breath-based analysis in disease diagnosis and management. Their breath-analysis devices focus on providing non-invasive products for the management of chronic diseases including asthma, COPD, and chronic pulmonary hypertension using a nexus of consumer technologies for preventative healthcare through sensors and algorithms. They enable medical researchers to detect biomarkers in a patient's breath to diagnose and monitor respiratory conditions.

DOmedia

Series A in 2016
DOmedia is an independent technology company that develops a software platform for buying and selling out of home media. The company's cloud-based applications connect buyers and sellers to leverage marketplace effects, eliminate labor, and improve reporting and analytics. DOmedia's software empowers agencies, vendors, and brands.

DecisionDesk

Debt Financing in 2013
DecisionDesk is a recruitment, application, and enrollment management solution for Higher Education Institutions. DecisionDesk manages the admissions process, from prospect to decision. DecisionDesk saves institutions time and money with its next-generation admissions and enrollment platform. DecisionDesk's cloud-based solution includes complete supplemental materials management, online routing and review, video profiles, reporting, and CRM/SIS integration.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.